-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.50342.71% Upside
Immutep Limited Frequently Asked Questions
-
What analysts cover Immutep Limited?
Immutep Limited has been rated by research analysts at Robert W. Baird, Capital One Financial in the past 90 days.